Ann Mooney, VP of clinical research at American Renal Associates told us, that the investigative site network is comprised of nephrologists and a dedicated study coordinator to expand upon research.
“The development of a research program was a natural extension of the ARA commitment to improve the care of kidney patients and foster physician autonomy,” said Mooney.
The American Renal Clinical Research Services (ARCRS), will provide physician partners and sponsors with the opportunity to bring research to kidney care patients.
Mooney further explained, “We believe it is our moral imperative to advance the care of kidney patients through research.”
“A centrally coordinated, renal specialty research program allows for more expansive offering of research participation to kidney patients across our organization. It also provides CROs [contract research organizations] and sponsors with more efficient and streamlined processes when deploying a study in the dialysis and chronic kidney disease [CKD] settings.”
According to Mooney, the ARCRS will provide a full suite of site network oversight for investigators. It will also offer study management services to CROs and sponsors.
Renal research has been expanding across the US, as researchers aim to gain a greater understanding of the disease and potential treatments. In August 2018 Frenova Renal Research, a CRO specializing in renal research established a site in Louisiana where CKD is highly prevalent. Frenova has expanded its sites over the years, and research centers like High Point Clinical Trials Center opened specific trial sites to expand the renal research network.